Comparative Pharmacology
Head-to-head clinical analysis: ADRENACLICK versus SYMJEPI.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ADRENACLICK versus SYMJEPI.
ADRENACLICK vs SYMJEPI
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Epinephrine is a direct-acting sympathomimetic amine that acts on alpha- and beta-adrenergic receptors. Alpha-1 receptor activation causes vasoconstriction, increasing blood pressure and reducing mucosal edema. Beta-1 receptor activation increases heart rate and contractility. Beta-2 receptor activation causes bronchodilation and vasodilation.
Symjepi (epinephrine) is a direct-acting sympathomimetic amine that acts on alpha- and beta-adrenergic receptors. Alpha-adrenergic receptor activation leads to vasoconstriction, increased peripheral vascular resistance, and decreased mucosal edema. Beta-adrenergic receptor activation results in bronchodilation, positive inotropic and chronotropic cardiac effects, and relaxation of gastrointestinal smooth muscle.
100 to 200 mcg sublingually as needed for severe allergic reaction, may repeat every 5-15 minutes.
0.3 mg intramuscular (IM) or subcutaneous (SC) injection into anterolateral aspect of thigh, repeat every 5-15 minutes as needed for anaphylaxis.
None Documented
None Documented
2.0-2.5 hours in adults with normal renal function; prolonged in renal impairment (up to 24 hours in anuria).
The terminal elimination half-life of epinephrine is approximately 2-3 minutes when administered intravenously. This short half-life reflects rapid metabolic clearance and necessitates continuous infusion for sustained effect. After intramuscular injection, absorption is slower, but elimination half-life remains brief (about 2-5 minutes for the beta phase). The clinical context: Due to rapid clearance, the drug's effects wane quickly after discontinuation.
Primarily renal (80-90% as unchanged drug via glomerular filtration and active tubular secretion), with 10-20% fecal via biliary elimination.
Epinephrine is rapidly metabolized in the liver and other tissues by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO). Metabolites, primarily metanephrine and vanillylmandelic acid (VMA), are excreted in urine. Less than 5% of administered dose is excreted unchanged in urine. Biliary/fecal elimination is negligible.
Category C
Category C
Adrenergic Agonist
Adrenergic Agonist